Literature DB >> 20551475

REVIEW PAPER: pathology of animal models of alphavirus encephalitis.

K E Steele1, N A Twenhafel.   

Abstract

The encephalitides caused by Venezuelan (VEEV), eastern (EEEV), and western (WEEV) equine encephalitis viruses are important natural diseases of horses and humans and potential agents of biowarfare or bioterrorism. No licensed vaccines or specific therapies exist to prevent or treat human infections with VEEV, EEEV, or WEEV. Well-characterized animal models are needed to support the development of such medical countermeasures under the United States Food and Drug Administration's "Animal Rule." This review focuses on the pathological features and pathogenetic mechanisms of these alphaviral encephalitides in animal models, with an emphasis on aerosol infections. Infection of mice, nonhuman primates, and other species with VEEV, EEEV, and WEEV causes encephalitis and often death. There is great variability in the specific manifestations of disease in the different models, however. Many aspects of the disease in animal models and in humans remain to be characterized using modern methods. Especially needed is a better understanding of the fundamental mechanisms involved in 3 key phases of the pathogenesis of alphavirus encephalitis. These are the early extraneural phase, the process of neuroinvasion itself, and virus and host factors related to neurovirulence. A greater understanding of these aspects could provide avenues for the development of medical countermeasures and better establish suitable animal models of alphavirus encephalitis for testing them under the Animal Rule.

Entities:  

Mesh:

Year:  2010        PMID: 20551475     DOI: 10.1177/0300985810372508

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  53 in total

1.  Manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development.

Authors:  Pennelope K Blakely; Phillip C Delekta; David J Miller; David N Irani
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

3.  Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.

Authors:  Amber B Rico; Aaron T Phillips; Tony Schountz; Donald L Jarvis; Ronald B Tjalkens; Ann M Powers; Ken E Olson
Journal:  Virology       Date:  2016-09-12       Impact factor: 3.616

4.  Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Authors:  Aaron T Phillips; Amber B Rico; Charles B Stauft; Sean L Hammond; Tawfik A Aboellail; Ronald B Tjalkens; Ken E Olson
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.

Authors:  Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton
Journal:  Am J Trop Med Hyg       Date:  2014-05-19       Impact factor: 2.345

6.  Discovery of anthranilamides as a novel class of inhibitors of neurotropic alphavirus replication.

Authors:  Scott J Barraza; Philip C Delekta; Janice A Sindac; Craig J Dobry; Jianming Xiang; Richard F Keep; David J Miller; Scott D Larsen
Journal:  Bioorg Med Chem       Date:  2015-02-11       Impact factor: 3.641

Review 7.  Antibodies for biodefense.

Authors:  Jeffrey W Froude; Bradley Stiles; Thibaut Pelat; Philippe Thullier
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

8.  Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Authors:  Janice M Rusnak; Lesley C Dupuy; Nancy A Niemuth; Andrew M Glenn; Lucy A Ward
Journal:  Comp Med       Date:  2018-10-03       Impact factor: 0.982

9.  The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses.

Authors:  Subhajit Poddar; Jennifer L Hyde; Matthew J Gorman; Michael Farzan; Michael S Diamond
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.

Authors:  Phillip C Delekta; Craig J Dobry; Janice A Sindac; Scott J Barraza; Pennelope K Blakely; Jianming Xiang; Paul D Kirchhoff; Richard F Keep; David N Irani; Scott D Larsen; David J Miller
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.